Clinical Applications of Medicinal Cannabis in Psychiatry: A 2020 Systematic Review
Introduction In this clinically-focused systematic review, Sarris et al. (2020) examine the evidence for medicinal cannabis in psychiatric disorders, including […]
Medicinal Cannabis for Mental Health: A 2020 Review of Its Benefits and Risks
Introduction Medicinal cannabis has gained attention for its potential to help with mental health issues. In 2020, researchers led by
Ketamine in Preclinical Memory Deficit Models for Schizophrenia: Insights from Suárez Santiago et al. (2023)
Introduction In a 2023 study published in Behavioral Pharmacology, Suárez Santiago and colleagues investigated the use of ketamine as a
Ketamine and Memory in Schizophrenia: A New Research Perspective (2023)
Introduction Schizophrenia is a challenging mental illness that can cause problems with memory and thinking. Researchers like Dr. Suárez Santiago
Alcohol and Cannabis Use Disorders: Clinical Challenges and Advances (2022)
Introduction In a 2022 commentary in the American Journal of Psychiatry, Dr. Ned H. Kalin highlights the pressing need to
Understanding Alcohol and Cannabis Use Disorders: Insights from Dr. Kalin (2022)
Introduction Alcohol and cannabis are commonly used substances, but they can lead to serious health problems when abused. Dr. Ned
Ketamine for Eating Disorders: Emerging Evidence and Future Directions
Introduction Eating disorders such as anorexia nervosa and binge eating disorder are notoriously difficult to treat. In their 2022 publication
Ketamine and Eating Disorders: A New Hope for Recovery
Introduction Eating disorders like anorexia and binge eating can be tough to treat, and current therapies don’t always work for
Clinical Trial Insights: Ketamine’s Expanding Role in Psychiatry (Peyrovian et al., 2020)
Introduction: Peyrovian et al.’s 2020 review in the Journal of Psychiatric Research summarizes registered clinical trials evaluating ketamine for psychiatric
Ketamine’s Role in Mental Health Treatment: New Hope from Clinical Trials (Peyrovian et al., 2020)
Introduction: In 2020, Peyrovian and colleagues published an analysis of registered clinical trials investigating ketamine as a treatment for psychiatric